Biotest AG (XTER:BIO3) Purchase Of Property, Plant, Equipment : €0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Purchase Of Property, Plant, Equipment?

Biotest AG's purchase of property, plant, equipment for the three months ended in Sep. 2024 was €0.0 Mil. It means Biotest AG spent €0.0 Mil on purchasing property, plant, equipment. Biotest AG's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was €0.0Mil.

Compared with last quarter (€0.0 Mil in Jun. 2024 ), Biotest AG spent the same money on purchasing property, plant, equipment in Sep. 2024 (€0.0 Mil).

Biotest AG Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Biotest AG's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Purchase Of Property, Plant, Equipment Chart

Biotest AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

Get a 7-Day Free Trial

Biotest AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Purchase Of Property, Plant, Equipment	Get a 7-Day Free Trial															-	-	-	-	-

Biotest AG Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Biotest AG Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Biotest AG's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

0N70:UK BIO3:Austria

Address

Landsteinerstrasse 5, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.

Executives

Dr. Katrin Bernöster	Vice President Corp. Project + Portfolio Management
Dr. Martin Reinecke	Senior Vice President plasma alliances and proteine supply
Stephan Fleck	Vice President Corporate Controlling
Dr. Jörg Schüttrumpf	VP Corp. Research &Development
Michael Moritz	VP CC Materials & Facility Management

Biotest AG Headlines

No Headlines